Ken Griffin Trans Medics Group, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$135.68 - $176.11 $7.16 Million - $9.3 Million	52,800 Added 107.98%	101,700 $16 Million
Q2 2024 Aug 14, 2024	SELL	$72.62 - $150.62 $820,606 - $1.7 Million	-11,300 Reduced 18.77%	48,900 $7.37 Million
Q1 2024 May 15, 2024	BUY	$70.86 - $89.93 $3.45 Million - $4.38 Million	48,700 Added 423.48%	60,200 $4.45 Million
Q4 2023 Feb 14, 2024	SELL	$36.74 - $81.08 $345,356 - $762,152	-9,400 Reduced 44.98%	11,500 $907,000
Q3 2023 Nov 14, 2023	BUY	$53.47 - $96.07 $336,861 - $605,241	6,300 Added 43.15%	20,900 $1.14 Million
Q2 2023 Aug 14, 2023	BUY	$66.23 - $88.73 $99,345 - $133,095	1,500 Added 11.45%	14,600 $1.23 Million
Q1 2023 May 15, 2023	BUY	$53.63 - $82.33 $160,890 - $246,990	3,000 Added 29.7%	13,100 $992,000
Q4 2022 Feb 14, 2023	SELL	$39.08 - $64.29 $406,432 - $668,616	-10,400 Reduced 50.73%	10,100 $623,000
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $646,980 - $1.14 Million	20,500 New	20,500 $856,000

397

31.7M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.03B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.